[ANAB] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[ANAB] AnaptysBio, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -57.87%
Quarter Report
ANAB's Result
ANAB's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 10,287 63,175 75,000 8,000 5,000 10,000 16,684 -7.73%
PBT -128,700 -57,796 -19,931 -97,488 -61,848 -30,070 -4,259 76.44%
Tax 24 -603 -11 -152 -192 1,821 205 -30.04%
NP -128,724 -57,193 -19,920 -97,336 -61,656 -30,070 -4,259 76.44%
Tax Rate - - - - - - - -
Total Cost 139,011 120,368 94,920 105,336 66,656 40,070 20,943 37.06%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,251.33 -90.53 -26.56 -1,216.70 -1,233.12 -300.70 -25.53 91.24%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -4.57 -2.08 -0.73 -3.60 -2.50 -1.52 -0.23 64.53%
EPS Diluted -4.57 -2.08 -0.73 -3.60 -2.50 -1.52 -0.23 64.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.